Blood Plasma Market Grows on High Demand for Immunoglobulin & Rare Disease Therapies, 2025-2032 | CSL Behring, Grifols, Takeda Pharmaceutical Company Limited (formerly Shire)

The Blood Plasma Industry is witnessing robust evolution driven by advancements in therapeutic applications and increasing demand for plasma-derived products. Innovations in plasma fractionation and enhanced donor recruitment strategies are significantly impacting the industry size and business growth globally. The blood plasma market is a critical component of healthcare, addressing various medical conditions such as immunodeficiencies and trauma-related treatments. The Global Blood Plasma Market size is estimated to be valued at USD 38.8 million in 2025 and is expected to reach USD 79.5 million by 2032, exhibiting a compound annual growth rate (CAGR) of 10% from 2025 to 2032. This market forecast underscores an expanding industry share and highlights emerging market opportunities driven by rising market demand and evolving market dynamics.

Request Sample Copy of this Report (Use Corporate eMail ID to Get Higher Priority) at : https://www.coherentmarketinsights.com/insight/request-sample/7914

➤ Actionable Insights

● Blood plasma production capacity grew by approximately 12% in 2024, with regional plasma collection centers enhancing their outputs to meet increasing clinical demand.
● Pricing for plasma-derived therapies in 2025 averaged a 5% increase year-on-year, driven by higher raw material costs and advanced processing technologies.
● Export volumes from North America surged by 8% in 2024, reflecting strong global demand and strategic distribution expansions.
● Import dynamics in Asia Pacific show a 15% increase, influenced by growing healthcare infrastructure and rising awareness of plasma therapies.
● Use cases across autoimmune disorders and surgical applications expanded steadily, accounting for nearly 40% of the total plasma utilization in 2025.

➤ Market Segment and Regional Coverage

● By Product Type: Fresh Frozen Plasma, Cryoprecipitate, Plasma-derived Medicinal Products (such as clotting factors, immunoglobulins), and Others.
● By Application: Immune Deficiency Disorders, Hemophilia Treatment, Trauma and Surgical Procedures, Infectious Diseases, and Others.
● By End-user: Hospitals, Diagnostic Laboratories, Research Institutes, and Plasma Centers.

Regional and Country Analysis:

● North America: U.S. and Canada
● Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
● Europe: Germany, U.K., Spain, France, Italy, Benelux, Denmark, Norway, Sweden, Russia, and Rest of Europe
● Asia Pacific: China, Taiwan, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Australia, and Rest of Asia Pacific
● Middle East & Africa: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Israel, South Africa, North Africa, Central Africa, and Rest of MEA

Get the Sample Copy of the Research Report: https://www.coherentmarketinsights.com/insight/request-sample/7914

➤ Key Players

● CSL Behring
● Grifols
● Takeda Pharmaceutical Company Limited
● Octapharma
● Kedrion Biopharma
● Bio Products Laboratory
● LFB Group
● Sanquin Plasma Products
● China Biologic Products Holdings, Inc
● ADMA Biologics
● GC Pharma
● CSL Plasma
● Emergent BioSolutions
● Kamada
● Centurion Pharma
● Competitive strategies include CSL Behring's recent acquisition of plasma collection centers in North America, increasing its plasma supply chain integration and market revenue considerably in 2024.
● Grifols expanded its biologics manufacturing capacity through technology upgrades in Spain and the U.S., enhancing production efficiency and reinforcing its industry size in 2025.
● Takeda Pharmaceutical Company Limited entered strategic partnerships with regional distributors in Asia Pacific, boosting market share and establishing stronger footholds by late 2024.

➤ Growth factors

● Increasing prevalence of immune deficiency diseases globally has accelerated demand for plasma-derived immunoglobulins, driving overall market growth by nearly 11% annually.
● The rising number of plasma donors, supported by optimized donor recruitment campaigns in the U.S. and Europe, improved plasma availability and industry trends towards self-sufficiency.
● Technological innovations in pathogen reduction and fractionation processes have raised plasma product safety standards, opening new clinical applications and augmenting market scope.
● Government initiatives promoting plasma donation and reimbursement policies further contribute to favorable market dynamics in key regions.

➤ Market Trends

● Enhanced automation in plasma fractionation facilities has increased operational efficiency, reducing turnaround time by 15% in leading production hubs during 2024.
● Adoption of recombinant plasma products and alternative therapies is gradually influencing market dynamics though plasma-derived products remain dominant.
● Digital platforms facilitating donor engagement and plasma collection logistics have optimized supply chain management and boosted market growth strategies in recent years.
● Geographical expansion of plasma collection centers in Latin America and Asia Pacific reflects emerging business growth and rising healthcare expenditure.
● Increasing awareness campaigns on plasma donation benefits contribute significantly to expanding donor pools, as evidenced by rising plasma collection volumes in 2025.

➤ Key Takeaways

● Immune Deficiency Disorders dominate the application segment, driven by rising diagnosis rates and therapeutic demand.
● Fresh Frozen Plasma represents a key product type segment with expanding clinical utilization in trauma and surgical applications.
● Hospitals remain the foremost end-users, accounting for a substantial portion of market revenue owing to diversified plasma therapy treatments.
● North America leads with advanced plasma collection infrastructure and technological innovation in production processes.
● Asia Pacific region displays rapid growth potential due to increasing healthcare investments and expanding donor base.
● Europe continues to advance through regulatory support and robust plasma donation programs enhancing local market opportunities.

Buy the Complete Report with an Impressive Discount (Up to 25% Off) at: https://www.coherentmarketinsights.com/insight/buy-now/7914

❓ Frequently Asked Questions

1. Who are the dominant players in the Blood Plasma Market?
The Blood Plasma Market's key players include CSL Behring, Grifols, Takeda Pharmaceutical Company Limited, Octapharma, Kedrion Biopharma, Bio Products Laboratory (BPL), and LFB Group, among others, leading through strategic expansions and product innovations.

2. What will be the size of the Blood Plasma Market in the coming years?
The Blood Plasma Market is projected to grow from an estimated USD 38.8 million in 2025 to USD 79.5 million by 2032, at a CAGR of 10%, reflecting substantial business growth prospects.

3. Which end-users industry has the largest growth opportunity?
Hospitals form the largest end-user industry segment, driven by the growing prevalence of immune deficiency disorders and trauma care requiring plasma-derived products.

4. How will market development trends evolve over the next five years?
Market trends suggest increased automation, digitalization of plasma collection, and expansion into emerging regions, underpinning sustained market growth and diversification of product portfolios.

5. What is the nature of the competitive landscape and challenges in the Blood Plasma Market?
The competitive landscape is marked by integration of plasma supply chains, technological advancements, and strategic partnerships. Challenges include donor recruitment, regulatory compliance, and cost management in production.

6. What go-to-market strategies are commonly adopted in the Blood Plasma Market?
Key strategies include acquisitions of plasma collection centers, regional partnerships for distribution expansion, capacity enhancement through technology upgrades, and donor engagement via digital platforms.

Author of this Marketing PR:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.

📞 Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
U.S.: + 12524771362
U.K.: +442039578553
AUS: +61-2-4786-0457
INDIA: +91-848-285-0837

About CMI:

Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

This release was published on openPR.